China AIDS Survey

What's New?  
Glossary
Chronologies
Documents and Statements
Links
Publications

About China AIDS Survey
(中文)


AIDS in China - 1 Mother-to-Infant HIV Transmission: Its Status, Crisis and Countermeasures

By:  Cao Yunzhen and Li Guanhan of the Laboratory of Clinical Virology of the Center for AIDS Prevention and Control, the Ministry of Health, Beijing 100050; Wang Shiyi of Kunming Station for Disease Control; Cheng Hehe of Yunnan Station for Pubic Health and Disease Control; Sun Feng of Yili Station for Public Health and Disease Control, Xinjiang; Zhou Zengquan of Kunming Hospital of Infectious Diseases; and He Yun of the Sixth People's Hospital in Zhengzhou:

Shanghai Zhonghua Chuanranbing Zazhi Vol. 20 No 3 in Chinese 15 Jun 02 pp 185-188


1. Situation of Mother-to-Infant Transmission of HIV 1 Worldwide


HIV/AIDS has become a major cause of death for children around the world. In 90 percent of the cases, HIV is transmitted from mother to child. It was estimated that 2,400,000 HIV-infected women gave birth, creating 600,000 HIV-infected babies every year. Everyday, 1600 newborns are infected with HIV. In Africa, infant mortality rose by 75 percent and child mortality increased by 100 percent because of HIV infection. In Uganda, 34 percent of its HIV-infected children died before reaching the age of one, 66 percent died before three, and 75 percent died before five. HIV/AIDS has created more than 11 million orphans who lost both parents. HIV is primarily a sexually-transmitted disease. Developing nations are most vulnerable to its threat. In Africa, HIV has been running rampant for quite some time. In many areas, more than 20 percent of the pregnant women have been infected already. Most children were infected during birth or breast feeding. Very few were infected in the uterus. The HIV-1 transmission rate in the perinatal period is 20 to 42 percent [1]. In developing nations breast feeding is an important risk factor in the vertical transmission of HIV-1. The infection rate is substantially higher in developing nations than that in industrialized countries.

In recent years, it is possible to block mother-to-infant HIV transmission by drugs, especially in western industrialized nations. With long-term use of AZT and formula feeding, the mother-to-infant HIV-1 transmission rate has fallen to less than 5 percent. Since 1992, clinical trials began in the United States and France according to Protocol PACTG 076. AZT was given starting from 14 to 32 weeks of pregnancy. The drug was administered intravenously during childbirth. The newborn was also given the drug for six weeks. This protocol lowered the mother-to-infant HIV transmission rate by 67 percent [2]. Afterward, a short-term AZT protocol was also found to be successful [3]. In a recent joint study carried out by Uganda and the United States, a few units of nevirapine (NVP) was given to pregnant women during labor and to newborns less than three days old. This protocol was found to have reduced perinatal HIV-1 transmission rate by 47 percent. (This is equivalent to the effect of the short-term of AZT.) According to a cost estimate made by a drug manufacturer, the entire protocol costs less $4 [4]. This is great news for developing nations.

2. Female HIV-Infected Patients in China

Among adults in China, HIV-1 is primarily transmitted through intravenous (IV) injection of illicit drugs, unprotected sex, and illegal blood trade. Let us take Yunnan as an example. Between 1989 and 1994, HIV-1 infection was confined to IV drug users in the southwestern border. It began to spread across the province in 1995. Between 1986 and the end of 1998, a total of 580,036 people were put under surveillance, and 5,604 were found to be HIV-1 positive. Among these people, there were 854 females. They represented approximately 15 percent of the total. As for the vehicle of infection, 65 percent came from needle-sharing, and 23 percent from sexual transmission [5]. The Guangxi Zhuang Autonomous Region in southwestern China is an area widely open to the outside world. Since AIDS monitoring began in 1986 until 1995, only 10 cases of HIV-1 positive patients were found. They were either foreigners or people from outside the region. However, since the first discovery of HIV-1 infected patients among drug addicts in western Guangxi in April 1996, the rate of transmission has accelerated noticeably. By the end of 1999, a cumulative total of 1175 HIV-1 positive cases were discovered, and 16.1 percent of them were females. This figure is higher than those in other provinces in China. Among the HIV-positive patients, 76 percent were infected were IV drug users. In this category, 20.8 percent were women. This is the highest percentage in China. In addition, these IV drug users sexually transmitted the virus to their spouses and partners. Most of these female IV drug users had multiple sex partners or were engaged in prostitution.

Prostitution is on the rise from cities to the countryside. Venereal diseases, eradicated in the 1960s and 1970s, are spreading across China at an unbelievably high speed. The total number of venereal disease cases across the country reached 358,324 in 2000. Compared to 1997, it increased by 87.53 percent. It is 28.5 times of that in 1987, as shown in Table 1. The rapid rise of commercial sexual behavior and venereal diseases not only negatively impacts the physical and mental health of young women, but also helps the transmission of HIV. According to surveys of customers of prostitutes done in Yunnan, no HIV infected patient was found between 1995 and 1997. In 1998, the HIV infection rate was 0.3 percent. In 1999, it went up to 1.1 percent, which represented a 266.7 percent increase over one year. Among the prostitutes, there was no HIV infected person between 1992 and 1994. In 1995, the HIV infection rate was 0.5 percent. In 1999, it went up to 2.2 percent. At this rate of increase, it was estimated that the infection rate would reach 5.4 percent in 2003 [6].

Table 1 Female Venereal Disease Cases in China Between 1977 and 2000
 

Year

Cases

1977
1982
1987
1992
1997
1998
1999
2000

1
160
12,562
75,371
191,068
286,112
350,620
258,324


3. Status of Mother-to-Infant HIV Transmission in China

In 1992, there were two monitoring stations for pregnant women in Yunnan, and they were confined to the Dehong area. It grew to five in 1996. By 1998, it increased to 10, covering nine different areas, as shown in Table 2. The number of women and their spouses infected with HIV is rising. In 1999, the average HIV-1 infection rate for pregnant women was 0.2 percent (see Table 3). The first case of mother-to-infant transmission of HIV-1 in Yunnan was reported in 1995. To date, a total of 46 HIV-1 positive pregnant women have been discovered. Among the 52 newborns, 15 were infected with the HIV-1 virus (out of 42 children tested), as shown in Table 4. A rough estimate based on figures such as population, birth rate, and mean HIV infection rate for 1998 and 1999, at least 1500 pregnant women and 500 newborns were infected by the HIV virus annually [5, 6]. In Xinjiang, IV drug users account for 97 percent of its HIV infected population. Women represent 8 percent of the total. The first case of mother-to-infant transmission was reported in 1996. The baby died in 17 months [7, 8]. In 1999, 1200 pregnant women visiting OB/GYN clinics and admitted to hospitals were tested in Wulumuqi, and six of them were found to be HIV-1 positive. The rate of infection was 0.5 percent. In five cases, the virus was sexually transmitted. The remaining case was due to a tainted blood transfusion [9]. Between 1997 and 1999, a total of 22 HIV-1 positive pregnant women were found at monitoring sites and hospitals in Yili. This is on top of the six cases discovered in Wulumuqi. In most cases, the outcome of the newborns was not known. In 1998, three children from Anhui and Guangdong were tested positive for the HIV-1 antibody according to international adoption agencies, as shown in Table 5. Although additional rigorous tests eliminated the possibility of HIV-1 infection, it is obvious that their mothers were infected with the HIV-1 virus.

Table 2 Number of Monitoring Sites Detecting HIV-1 Positive Pregnant Women in Yunnan Between 1992 and 1999
 

  1992 1993 1994 1995 1996 1997 1998 1999
Number of Monitoring Sites 2 4 5 5 5 8 10 10
Number of Sites Detected HIV Infection 1 1 1 2 2 3 6 8


Table 3 HIV-1 Spousal Infection Rate and Pregnant Women Infection in Yunnan
 

Year Wives of IV Drug Users ( percent) Pregnant Women ( percent)
1986 - 1988
1990
1991
1992
1993
1994
1997
1999
ND
2/53 (3.8)
0/7 (0)
5/100 (5)
7/146 (4.8)
3/48 (6.25)
11/83 (13.3)
ND
ND
1/492 (0.2)
0/1234 (0)
1/2387 (0.04)
4/3567 (0.11)
0 - 0.6 (average 0.1)
0 - 1.6 (average 0.2)


Table 4 Distribution of Mother-to-Infant HIV-1 Transmission Cases in Certain Areas of China
 

Area HIV(+) Pregnant Women - Infant HIV/AIDS Status - -
- - HIV(+) HIV(-) Unknown Total
Yunnan
Guangdong
Guangxi
Fujian
Zhejiang
Anhui
Shanghai
Hubei
Henan
Hebei
Shanxi
Beijing
Liaoning
Xingjiang
46
8
2
1
1
2
2
1
15
2
1
2
2
17
15
1
0
1
1
1
2
1
6
1
1
0
0
4
28
4
1
0
0
0
0
0
8
1
0
2
2
8
9
3
2
0
0
1
0
0
2
0
0
0
0
7
52
8
3
1
1
2
2
1
16
2
1
2
2
19
Total 102 34 54 24 112


Table 5 Detection of HIV-1 Serum Antibody in Three Adopted Chinese Children
 

Province Test Date Age (months) Birth Date ELISA Antibody W.B. PBMC PCR
Anhui
Guangdong
Anhui
6/98
5/29/98
6/20/98
16
12
17
2/10/97
6/10/97
2/10/97
Positive (+)
Positive (+)
Positive (+)
Negative (-)
Suspicious
Negative (-)
Negative (-)
Negative (-)
Negative (-)


As of the end of 2000, there were only 23 cases of mother-to-infant HIV-2 transmission in China. Neither a retrospective nor a prospective study has been conducted even in high HIV infection rate areas. In addition, diagnostic equipment necessary to determine HIV infection in babies (less than 18 months old) is essentially not available locally. Hence, we do not have a precise picture on the status of mother-to-infant HIV-1 transmission and its rate of propagation. Based on the data collected by various local health and disease control organizations, we are not optimistic about the situation. Out of the 112 newborns (53 males, 52 females, and 7 unknowns) borne by 102 HIV-1 positive pregnant women, 34 were found to be HIV-1 positive, 54 were negative (4 blocked by NVP during birth), 2 were suspicious, and 22 were untested or waiting to be tested. 38.6 percent of the children (34/88) were HIV positive. As for the method of delivery, 50 delivered naturally, 11 gave birth by Caesarian section, 3 were induced, and 45 were unknown. The percentage of breast feeding was 80 percent (36/45). By region, Yunnan, Xinjiang, Henan, and Guangdong are the leaders, as shown in Table 4. However, there is no significance with regard to epidemiology. Based on the total number of HIV infected people reported, Guangxi and Sichuan should be the leaders. However, among the cases shown here, there were very few cases from these two areas. Of course, this is related to whether the local authority has begun this line of work. In addition, HIV-1 infection in Henan was brought under the limelight because of its illegal blood trade. Tests showed that 98 percent of the plasma and blood samples taken from some illegal blood trading stations in Henan were HIV-1 positive [10]. However, the status of HIV infection in the region is still unclear.

In conclusion, the status of mother-to-infant HIV infection in China may be far worse than people imagine today. As the HIV/AIDS situation deteriorates in China, the number of mother-to-infant HIV transmission cases will also rise. Chinese children are under serious threat by HIV/AIDS.

4. Measures To Block Mother-to-Infant HIV Transmission


In the Second Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants held in Montreal, Canada in September 1999, it was pointed out that the HIV epidemic had reached an alarming scale. Were it allowed to propagate at the present rate, its threat will exceed the sum of all other health problems combined. According to the WHO, without any intervention, there will be 5 to 10 million HIV infected children in the world in the next 10 years, and 90 percent of them will be in Africa and Asia. To this end, the Conference sent an emergency plea to the world to "prevent HIV transmission from mothers to infants." Various governments, non-governmental organizations, and pharmaceutical companies were urged to donate to this cause, and to implement effective measures to block perinatal transmission of the HIV virus.

Mother-to-infant HIV transmission may take place in the uterus, during the perinatal period, or through breast feeding. However, there are many other factors determining whether this mother-to-infant transmission occurs, including the mother's disease stage, virological characteristics, immunological state, placenta factors (such as physical damage or inflammation), genetic factors (such as polymorphism of ancillary receptor), and obstetric factors (such as method of delivery) [11-16]. The placenta may become more "permeable" due to infection by another pathogen to increase the probability of mother-to-infant transmission of the HIV virus. Many studies showed that the virus level in the mother was closely related to the mother-to-infant transmission of the HIV-1 virus. However, there is not a clear critical value between transmission and no transmission. The factors related to the fetus or infant, such as CTL response and polymorphism of the HIV ancillary receptor, may also have some influence. The method of delivery has an important effect on mother-to-infant transmission of the disease. Caesarian section can shorten and minimize the contact between the baby and vaginal secretion and maternal blood, which can drastically reduce the rate of occurrence. In addition, washing the vagina and giving supplemental nutrients to pregnant women (such as Vitamin A) can also decrease the rate of mother-to-infant transmission. In conclusion, various mutually interacting factors are determining whether the HIV virus will be transmitted from a mother to her infant. Hence, we should pay attention to all possible factors. There is a need to conduct additional studies.

To block HIV transmission, based on its propagation mechanism and influencing factors, the most effective available measures are as follows: drug blockade, formula feeding, and Caesarian section. In China, HIV is primarily affecting minorities at the border and rural areas in middle of the country. Due to factors such as poverty, low culture standard, and shame, it is extremely difficult to promote Caesarian section. Specific local situation must be taken into account to decide whether formula feeding should be promoted. In Asia, the rate of mother-to-infant transmission is approximately 30 percent. Only 1/3 of the cases were infected by mother's milk. Breast feeding has many advantages. Whether to unilaterally promote formula feeding must be carefully considered. It is best to explain the advantages and disadvantages of breast feeding to the patient, and allow the patient to make her own decision. Heating the milk before feeding is another viable approach. Of course, measures such as vaginal washing and vitamin supplement are also very important. They should be adopted whenever possible.

Using an anti-reverse-transcription drug as an intervening treatment is the most effective measure to block mother-to-infant transmission of the HIV-1 virus. Taking AZT following a standard protocol is very effective against mother-to-infant transmission. A short-term protocol is also effective. However, it is not suited for remote and rural areas due to its high cost and complicated protocol. In these areas, we should promote the use of a single dose of NVP [4, 17]. We used NVP to treat four HIV-1 positive pregnant women in Kunming and Dalian, and followed up for 5 to 9 months to date. Serum specimens of the four infants showed negative HIV RNA, as shown in Table 6. Of course, it is better to use the standard AZT protocol in cities and developed areas along the coast. We may even be better off using the AZT + 3TC protocol. Based on the latest report, the latter could lower the mother-to-infant transmission rate to 1.6 percent.

Table 6 HIV-1 Positive Pregnant Women and Their Children Using NVP as the Blocking Agent
 

Number Birth Date Path Delivery Method Delivery Date - - - - -
          Number Sex Feeding HIV-1 RNA Spouse Status
YN08M
YN08M
YN33M
DL02M
06/75
09/78
03/68
04/73
Sexually
IVDC
Unknown
Sexually
Natural
Caesarian
Caesarian
Natural
09/12/00
08/25/00
09/30/00
12/14/00
YN08C
YN20C
YN33C
DL02C
F
M
F
M
Formula
Formula
Formula
Formula
Negative
Negative
Negative
Negative
HIV1(+)(IVDU)
Unknown
Muslin, HIV1(-)
HIV1(+)


From the overall standpoint, the fundamental approach to preventing HIV transmission from mothers to infants is to control HIV infection in China. However, various levels of government still need to formulate and implement a series of effective countermeasures to prevent young women who are either already HIV-infected or become HIV-infected from transmitting the disease to the next generation. We believe that we have to launch an effective campaign to increase people's awareness of HIV related issues, including methods to prevent mother-to-infant transmission. Next, we have to seek the funding necessary to establish a foundation to pay for NVP treatment. Drugs should be free in remote and poor areas for old and young patients. Third, we must expand urine HIV screening in OB/GYN clinics and during pre-marital examinations. This reagent is already available in China. It will be manufactured domestically in the near future. It is a low cost and convenient method, and can easily be accepted by patients [19].

References

[1] Li Guanhan and Yu Dongmei, Information on the Second International Strategic Workshop on Mother-to-Infant HIV Transmission, Zhongguo Redai Yixue [China Tropical Medicine], Vol 1, 2001 pp 83 - 85.

[2] Connor EM, Speling RS, Gelber R, et al., Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type l with Zidovudine Treatment, N. Eng. J. Med., Vol 331, 1994 pp 1173 - 1180.

[3] Fiscus SA, Schoenbach VJ, and Wilfert C, Short Courses of Zidovudine and Perinatal Transmission of HIV, N. Eng. J. Med., Vol 340, 1999 pp 1040 - 1041.

[4] Guay LA, Musoke P, Fleming T, et al., Intrapartum and Neonatal Single Dose Nevirapine Compared with Zidovudine for Prevention of Mother-to-Child Transmission of HIV-1 in Kampala, Uganda: HIVNET 012 Randomized Trial, Lancet, Vol 354, 1999 pp 795 - 802.

[5] Pan Songfeng, Cheng Hehe, Zhang Jiapeng, et al., 1996 HIV Surveillance Report in Yunnan, Zhongguo Xingbing Aizibing Fangzhi [Control of Venereal Diseases and AIDS in China], Vol 3, 1997 pp 244 - 246.

[6] Cheng Hehe Zhang Jiapeng, Pan Songfeng, et al., Trend Analysis and Forecast of HIV Transmission in Yunnan, Zhongguo Xingbing Aizibing Fangzhi [Control of Venereal Diseases and AIDS in China], Vol 6, 2000 pp 257 - 260.

[7] Sun Fengm Dilixiati Sha, Nayila A, et al., First Case Report of Maternal HIV Transmission in Xinjiang, Zhongguo Xingbing Aizibing Fangzhi [Control of Venereal Diseases and AIDS in China], Vol 3, 1997 p 248.

[8] Lin Xuedong, Sun Feng, Pan Pingliang, et al., Identification of a Typical AIDS Family in China and Analysis of the Sequence of the env Gene of the Virus, Bingdu Xuebao [Chinese Journal of Virology], Vol 15, 1999 pp 7 - 13.

[9] Zhou Mei, Peng Hong, Zhang Zhongyuan, et al., Analysis of HIV Antibody Surveillance Data on 1200 Pregnant Women in Wulumuqi, Zhongguo Xingbing Aizibing Fangzhi [Control of Venereal Diseases and AIDS in China], Vol 6, 2000 pp 290 - 291.

[10] Li Shengwang and Sun Guijun, Analysis of Blood Quality at Underground Blood Stores, Zhongguo Xingbing Aizibing Fangzhi [Control of Venereal Diseases and AIDS in China], Vol 6, 2000 pp 12 - 13.

[11] Jin X, Roberts CG, Nixon DF, et al., Longitudinal and Cross-Sectional Analysis of Cytotoxic T Lymphocyte Responses and Their Relationship to Vertical Human Immunodeficiency Virus Transmission, ARIEL Project Investigators, J. Infect. Dis., Vol 178, 1998 pp 1317 - 1326.

[12] Zhang Y, Dragic T, Cao T, et al., Use of Corecepors Other Than CCR5 by Non-Syncytium-Inducing Adult and Pediatric Isolates of Human Immunodeficiency Virus Type 1 Is Rare in vitro, J. Virol., Vol 72 pp 1998 pp 9337 - 9344.

[13] Kuhn L, Steketee RW, Weedon J, et al., The Perinatal AIDS Collaborative Transmission Study - Distinct Risk Factors for Intrauterine and Intrapartum Human Immunodeficiency Virus Transmission and Consequences for Disease Propagation in Infected Children, J. Infect. Dis., Vol 179, 1999 pp 52 - 58.

[14] Van de Perre P, Transmission of Human Immunodeficiency Virus Type 1 Through Breast-Feeding: How Can It Be Prevented?, J. Infect. Dis., Vol 179 (Suppl. 3), 1999 pp S405- S407.

[15] Van Tine BA, Shaw GM and Aldrovanti G, Mother-to-Infant Transmission of the Human Immunodeficiency Virus During Primary Infection, N. Eng. J. Med., Vol 341, 1999 p 1548.

[16] Shaffer N, Roongpisuthipong A, Siriwasin W, et al., Maternal Virus Load and Perinatal Human Immunodeficiency Virus Type 1 Subtype E Transmission, Thailand Bangkok Collaborative Perinatal HIV Transmission Study Group, J. Infect. Dis., Vol 179, 1999 pp 590 - 599.

[17] Heltzer NE, Perinatal Screening, Infants and Zidovudine, Post-Exposure Prophylaxis, Adverse Events with Nevirapine, The AIDS Reader, Vol 11, 2001 pp 81 - 82.

[18] Mandelbrot L, Landreau Mascaro A, Rekacewicz C, et al., Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV 1, JAMA, Vol 285, 2001 pp 2083 - 2093.

[19] Lun Wenhuai, Li Li, Huang Qin, et al., Analysis of Detection of HIV-1 Antibody in Urine Specimens from HIV Infected Patients by ELISA, Zhongguo Xingbing Aizibing Fangzhi [Control of Venereal Diseases and AIDS in China], Vol 7, 2001 pp 32 - 34.

MS received 02 Dec 2001.

Editor: Li Xin

Affiliations of Authors: Cao Yunzhen and Li Guanhan are from the Laboratory of Clinical Virology of the Center for AIDS Prevention and Control, the Ministry of Health, Beijing 100050; Wang Shiyi is at the Kunming Station for Disease Control; Cheng Hehe is at the Yunnan Station for Pubic Health and Disease Control; Sun Feng works at the Yili Station for Public Health and Disease Control, Xinjiang; Zhou Zengquan works at the Kunming Hospital of Infectious Diseases; and He Yun is at the Sixth People's Hospital in Zhengzhou.


[Description of Source: Shanghai Zhonghua Chuanranbing Zazhi in Chinese -- quarterly journal of the Shanghai Branch of the Chinese Medical Association]
 

[FBIS Translated Text]

© 2003 China AIDS Survey
Monterey, California